Publication
CORALreef Lipids
DOI 10.1056/NEJMoa2511002
Randomized placebo-controlled Phase 3: крупное устойчивое снижение LDL-C; primary endpoint — lipid surrogate, не cardiovascular events.
No news refers to this card yet.
Also in the catalogue
- Circulation/AHA 2025 abstract: REP-0003 in Ldlr-/- micePublication
- In Vivo Base Editing of PCSK9 with VERVE-102 for HypercholesterolemiaPublication
- Cyclodextrin-loaded nanobubbles reduce cholesterol and atherosclerosis in vivoPublication
- NEJM 28.08.2026 durability letter (CTX310)Publication
- Snip et al., Biomolecules 2022 (2HPβCD in ApoE-KO)Publication
- SSRI + антиагреганты после инфаркта, ретроспективная когортаPublication
Scales
Identifiers
- DOI
- 10.1056/NEJMoa2511002
Original sources
Details
- Journal
- N Engl J Med
- Year
- 2026
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.